Cyclo Therapeutics Inc (CYTH)

$0.62 -$0.00 (-0.47%) 4:37 PM 12/10/24
NASDAQ | $USD | Drug Manufacturers - Specialty & Generic

Stock Data

  • Market Cap

    $17.55M
  • Day's Range

    $0.60 - $0.64
  • Volume

    25,480
  • 52 Week Low / High

    $0.59 - $2.12
  • PE Ratio

    -
  • PEG Ratio

    -
  • Dividend Frequency

    -

CYTH's Dividend
-
Amount
-
Dividend Yield
Nov 30
Payment Date
-
Annual Dividend Amount
Dividend Streak
Hypothetical 10k Investment Jan 1, 2020
Capital Growth
Dividend Return to Date
Dividend Payout year Est.
Expenses
Total Return
Total Return %
Analyists Ranking
1
Strong Buy
0
Buy
2
Hold
0
Sell
0
Strong Sell
$5.00
Target Price

Company News

  • Pacira BioSciences Appoints Shawn Cross as Chief Financial Officer — Oct 21st, 2024

    Pacira BioSciences Seasoned Executive Brings More Than 25 Years of Global Financial and Operational Biopharmaceutical Leadership Experience TAMPA, Fla., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioi...

  • Pacira BioSciences Appoints Shawn Cross as Chief Financial Officer — Oct 21st, 2024

    Pacira BioSciences Seasoned Executive Brings More Than 25 Years of Global Financial and Operational Biopharmaceutical Leadership Experience TAMPA, Fla., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioi...

  • Pacira BioSciences Appoints Shawn Cross as Chief Financial Officer — Oct 21st, 2024

    Pacira BioSciences Seasoned Executive Brings More Than 25 Years of Global Financial and Operational Biopharmaceutical Leadership Experience TAMPA, Fla., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioi...

  • Pacira BioSciences Appoints Shawn Cross as Chief Financial Officer — Oct 21st, 2024

    Pacira BioSciences Seasoned Executive Brings More Than 25 Years of Global Financial and Operational Biopharmaceutical Leadership Experience TAMPA, Fla., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioi...

  • Pacira BioSciences Appoints Shawn Cross as Chief Financial Officer — Oct 21st, 2024

    Pacira BioSciences Seasoned Executive Brings More Than 25 Years of Global Financial and Operational Biopharmaceutical Leadership Experience TAMPA, Fla., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioi...

  • Pacira BioSciences Appoints Shawn Cross as Chief Financial Officer — Oct 21st, 2024

    Pacira BioSciences Seasoned Executive Brings More Than 25 Years of Global Financial and Operational Biopharmaceutical Leadership Experience TAMPA, Fla., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioi...

  • Pacira BioSciences Appoints Shawn Cross as Chief Financial Officer — Oct 21st, 2024

    Pacira BioSciences Seasoned Executive Brings More Than 25 Years of Global Financial and Operational Biopharmaceutical Leadership Experience TAMPA, Fla., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioi...

  • Pacira BioSciences Appoints Shawn Cross as Chief Financial Officer — Oct 21st, 2024

    Pacira BioSciences Seasoned Executive Brings More Than 25 Years of Global Financial and Operational Biopharmaceutical Leadership Experience TAMPA, Fla., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioi...

  • Pacira BioSciences Appoints Shawn Cross as Chief Financial Officer — Oct 21st, 2024

    Pacira BioSciences Seasoned Executive Brings More Than 25 Years of Global Financial and Operational Biopharmaceutical Leadership Experience TAMPA, Fla., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioi...

  • Pacira BioSciences Appoints Shawn Cross as Chief Financial Officer — Oct 21st, 2024

    Pacira BioSciences Seasoned Executive Brings More Than 25 Years of Global Financial and Operational Biopharmaceutical Leadership Experience TAMPA, Fla., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioi...

  • Pacira BioSciences Appoints Shawn Cross as Chief Financial Officer — Oct 21st, 2024

    Pacira BioSciences Seasoned Executive Brings More Than 25 Years of Global Financial and Operational Biopharmaceutical Leadership Experience TAMPA, Fla., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioi...

  • Pacira BioSciences Appoints Shawn Cross as Chief Financial Officer — Oct 21st, 2024

    Pacira BioSciences Seasoned Executive Brings More Than 25 Years of Global Financial and Operational Biopharmaceutical Leadership Experience TAMPA, Fla., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioi...

  • Cyclo Therapeutics, Inc. Completes Merger with Applied Molecular Transport Inc. — Dec 27th, 2023

    Combined company operating as Cyclo Therapeutics with primary focus on advancing Trappsol® Cyclo™ for the treatment of Niemann-Pick Disease Type C1 (NPC1) Cash runway extended into 2H 2024 with approximately $11.0 million cash on hand to fund operations GAINESVILLE, Fla., December 27,...

  • Pacira BioSciences Appoints Shawn Cross as Chief Financial Officer — Oct 21st, 2024

    Pacira BioSciences Seasoned Executive Brings More Than 25 Years of Global Financial and Operational Biopharmaceutical Leadership Experience TAMPA, Fla., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioi...

Similar Stocks

No similar stocks found.

Want to be notified on dividend changes?

Start manging your portfolio today.

Sign up for free